Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. scores highest on Nitro (92) and lowest on Price (8). Its PosiPenta is 53.82 out of 100, around the middle of similar companies.
On the Penta Grid this week, Iovance Biotherapeutics, Inc. is Grid #231 of 837 in the Healthcare sector in United States, and Grid #1,423 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Iovance Biotherapeutics, Inc. | 53.82 | 8 | 62 | 92 | 55 | 53 |
| Lantheus Holdings, Inc. | 61.65 | 41 | 75 | 90 | 62 | 40 |
| Rhythm Pharmaceuticals, Inc. | 35.77 | 2 | 47 | 63 | 27 | 40 |
| Ligand Pharmaceuticals Incorporated | 59.73 | 31 | 68 | 91 | 54 | 55 |
| Hims & Hers Health, Inc. | 41.96 | 3 | 75 | 53 | 32 | 47 |
| Chemed Corporation | 66.89 | 33 | 73 | 91 | 64 | 73 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -19.74 |
| P/B ratio | 8.53 |
EEarnings
| Trailing EPS | ₹-65.35 |
| Forward EPS | ₹-18.54 |
NNitro
| Price | 1290.02 |
| 52-week high | 1449.14 |
| 52-week low | 166.70 |
| Fall from 52-week high | 11.0% |
TTorque
| Return on equity (ROE) | -40.36% |
| Debt-to-equity | 0.06 |
AAnchor
| Beta (price swings) | 0.76 |
| Market cap | ₹58,434 Cr |
| Insider holding | 0.35% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Iovance Biotherapeutics, Inc.'s PosiPenta score?
Iovance Biotherapeutics, Inc.'s PosiPenta is 53.82 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Iovance Biotherapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Iovance Biotherapeutics, Inc. is Grid #231 of 837 in the Healthcare sector in United States, and Grid #1,423 of 4,000 in United States.
Which PosiPenta pillar is strongest for Iovance Biotherapeutics, Inc.?
Nitro (momentum), with a score of 92 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Iovance Biotherapeutics, Inc.?
Price (valuation), with a score of 8 out of 100: much weaker than most similar companies.
Has Iovance Biotherapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 1.03 points, from 52.79 to 53.82.
PositoAI is for research and education only and is not investment advice.